Brick & Kyle Associates’s Zimmer Biomet ZBH Stock Holding History

Brick & Kyle Associates’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-25,479	Closed	-$3.16M	–	74
2019 Q1	$3.16M	Buy	25,479 +286	+1%	+$32.5K	3.24%	13
2018 Q4	$2.54M	Buy	+25,193	New	+$2.83M	2.42%	14
2018 Q2	$2.81M	Sell	26,003 -366	-1%	-$39.8K	2.2%	16
2018 Q1	$2.79M	Buy	26,369 +155	+0.6%	+$18K	2.25%	16
2017 Q4	$3.07M	Hold	26,214	–	–	2.5%	14
2017 Q3	$2.98M	Buy	+26,214	New	+$3.03M	2.41%	14
2017 Q2	–	Sell	-582	Closed	-$69K	–	374
2017 Q1	$69K	Hold	582	–	–	0.05%	150
2016 Q4	$58K	Hold	582	–	–	0.05%	161
2016 Q3	$73K	Hold	582	–	–	0.06%	149
2016 Q2	$68K	Buy	582 +103	+22%	+$11.7K	0.06%	155
2016 Q1	$50K	Hold	479	–	–	0.04%	174
2015 Q4	$48K	Buy	479 +170	+55%	+$16.6K	0.04%	175
2015 Q3	$28K	Hold	309	–	–	0.03%	220
2015 Q2	$33K	Hold	309	–	–	0.03%	219
2015 Q1	$35K	Hold	309	–	–	0.03%	214
2014 Q4	$34K	Buy	+309	New	+$32.6K	0.03%	213

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Brick & Kyle Associates's ZBH Position: Q2 2019 in Review

Brick & Kyle Associates sold out of Zimmer Biomet (ZBH) in Q2 2019, closing a stake of 25,479 shares — an estimated $3.16M sold.

Brick & Kyle Associates first reported a position in ZBH in Q4 2014 and held it in 16 quarters. The position peaked at $3.16M in Q1 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q2 2019.

Brick & Kyle Associates reported no remaining Zimmer Biomet position as of Q2 2019 after selling out during the quarter.
Brick & Kyle Associates sold 25,479 Zimmer Biomet shares in Q2 2019, an estimated $3.16M.
Brick & Kyle Associates first reported a position in Zimmer Biomet in Q4 2014 and held it in 16 quarters.
Brick & Kyle Associates's Zimmer Biomet position peaked at $3.16M in Q1 2019.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2019.

Based on Brick & Kyle Associates's 13F filing for Q2 2019, filed 17 Jul 2019.